LISATA THERAPEUTICS, INC. Increase (Decrease) in Inventories
LISATA THERAPEUTICS, INC. (LSTA) reported Increase (Decrease) in Inventories of -$43.66 thousand for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-05-15.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2017-05-15
- LISATA THERAPEUTICS, INC. increase (decrease) in inventories for the quarter ending 2017-03-31 was -$43.66K, a 104.06% decline year-over-year.
- LISATA THERAPEUTICS, INC. increase (decrease) in inventories for the quarter ending 2016-12-31 was -$733.68K.
- LISATA THERAPEUTICS, INC. increase (decrease) in inventories for the quarter ending 2016-09-30 was -$833.80K, a 322.27% decline year-over-year.
- LISATA THERAPEUTICS, INC. increase (decrease) in inventories for the quarter ending 2016-06-30 was $1.16M.
- LISATA THERAPEUTICS, INC. increase (decrease) in inventories for fiscal 2016 was $670.55K, a 94.50% increase from fiscal 2015.
- LISATA THERAPEUTICS, INC. increase (decrease) in inventories for fiscal 2015 was $344.75K, a 73.41% decline from fiscal 2014.
- LISATA THERAPEUTICS, INC. increase (decrease) in inventories for fiscal 2014 was $1.30M, a 724.93% increase from fiscal 2013.
- LISATA THERAPEUTICS, INC. increase (decrease) in inventories for fiscal 2013 was $157.20K, a 66.21% decline from fiscal 2012.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 3 month as first filed | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 6 month as first filed | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 9 month as first filed | Increase (Decrease) in Inventories 12 month | Increase (Decrease) in Inventories 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2017-03-31 | -$43.66K 10-Q · filed 2017-05-15 | -$777.34K derived: sum of 2 quarters · filed 2017-05-15 | -$1.61M derived: sum of 3 quarters · filed 2017-05-15 | -$447.54K derived: sum of 4 quarters · filed 2017-05-15 | ||||
| 2016-12-31 | -$733.68K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-17 | -$1.57M derived: sum of 2 quarters · filed 2017-03-17 | -$403.88K derived: sum of 3 quarters · filed 2017-03-17 | $670.55K 10-K · filed 2017-03-17 | ||||
| 2016-09-30 | -$833.80K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $329.80K derived: sum of 2 quarters · filed 2016-11-07 | $1.40M 10-Q · filed 2016-11-07 | $967.36K derived: sum of 4 quarters · filed 2017-05-15 | ||||
| 2016-06-30 | $1.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $2.24M 10-Q · filed 2016-08-09 | $1.80M derived: sum of 3 quarters · filed 2017-05-15 | $2.18M derived: sum of 4 quarters · filed 2017-05-15 | ||||
| 2016-03-31 | $1.07M 10-Q · filed 2017-05-15 | $637.56K derived: sum of 2 quarters · filed 2017-05-15 | $1.01M derived: sum of 3 quarters · filed 2017-05-15 | $364.83K derived: sum of 4 quarters · filed 2017-05-15 | ||||
| 2015-12-31 | -$436.88K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-17 | -$61.74K derived: sum of 2 quarters · filed 2017-03-17 | -$709.61K derived: sum of 3 quarters · filed 2017-03-17 | $344.75K 10-K · filed 2017-03-17 | ||||
| 2015-09-30 | $375.13K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | -$272.73K derived: sum of 2 quarters · filed 2016-11-07 | $781.63K 10-Q · filed 2016-11-07 | $1.21M derived: sum of 4 quarters · filed 2016-11-07 | ||||
| 2015-06-30 | -$647.86K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $406.50K 10-Q · filed 2016-08-09 | $831.18K derived: sum of 3 quarters · filed 2016-08-09 | $940.48K derived: sum of 4 quarters · filed 2016-08-09 | ||||
| 2015-03-31 | $1.05M 10-Q · filed 2016-05-05 | $1.48M derived: sum of 2 quarters · filed 2016-05-05 | $1.59M derived: sum of 3 quarters · filed 2016-05-05 | $2.15M derived: sum of 4 quarters · filed 2016-05-05 | ||||
| 2014-12-31 | $424.69K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $533.98K derived: sum of 2 quarters · filed 2016-03-15 | $1.09M derived: sum of 3 quarters · filed 2016-03-15 | $1.30M 10-K · filed 2016-03-15 | ||||
| 2014-09-30 | $109.29K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $666.49K derived: sum of 2 quarters · filed 2015-11-05 | $872.08K 10-Q · filed 2015-11-05 | $1.61M derived: sum of 4 quarters · filed 2016-03-15 | ||||
| 2014-06-30 | $557.20K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $762.79K 10-Q · filed 2015-08-06 | $1.50M derived: sum of 3 quarters · filed 2016-03-15 | $2.00M derived: sum of 4 quarters · filed 2016-03-15 | ||||
| 2014-03-31 | $205.59K 10-Q · filed 2015-05-06 | $946.45K derived: sum of 2 quarters · filed 2016-03-15 | $1.44M derived: sum of 3 quarters · filed 2016-03-15 | -$65.76K derived: sum of 4 quarters · filed 2016-03-15 | ||||
| 2013-12-31 | $740.86K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $1.24M derived: sum of 2 quarters · filed 2016-03-15 | -$271.35K derived: sum of 3 quarters · filed 2016-03-15 | $157.20K 10-K · filed 2016-03-15 | ||||
| 2013-09-30 | $497.40K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | -$1.01M derived: sum of 2 quarters · filed 2014-10-30 | -$583.66K 10-Q · filed 2014-10-30 | $81.32K derived: sum of 4 quarters · filed 2015-03-02 | ||||
| 2013-06-30 | -$1.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | -$1.08M 10-Q · filed 2014-08-07 | -$416.08K derived: sum of 3 quarters · filed 2015-03-02 | -$1.13M derived: sum of 4 quarters · filed 2015-03-02 | ||||
| 2013-03-31 | $428.55K 10-Q · filed 2014-05-08 | $1.09M derived: sum of 2 quarters · filed 2015-03-02 | $380.23K derived: sum of 3 quarters · filed 2015-03-02 | $685.45K derived: sum of 4 quarters · filed 2015-03-02 | ||||
| 2012-12-31 | $664.98K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | -$48.32K derived: sum of 2 quarters · filed 2015-03-02 | $256.90K derived: sum of 3 quarters · filed 2015-03-02 | $465.28K 10-K · filed 2015-03-02 | ||||
| 2012-09-30 | -$713.30K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | -$408.08K derived: sum of 2 quarters · filed 2013-11-07 | -$199.70K 10-Q · filed 2013-11-07 | $1.23M derived: sum of 4 quarters · filed 2013-11-07 | ||||
| 2012-06-30 | $305.22K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | $513.60K 10-Q · filed 2013-08-08 | $1.94M derived: sum of 3 quarters · filed 2013-08-08 | $350.62K derived: sum of 4 quarters · filed 2013-08-08 | ||||
| 2012-03-31 | $208.38K 10-Q · filed 2013-05-09 | $726.30K 10-Q · filed 2012-05-11 | $1.64M derived: sum of 2 quarters · filed 2013-05-09 | $45.40K derived: sum of 3 quarters · filed 2013-05-09 | -$2.19M derived: sum of 4 quarters · filed 2013-05-09 | |||
| 2011-12-31 | $1.43M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-11 | -$162.98K derived: sum of 2 quarters · filed 2013-03-11 | -$2.40M derived: sum of 3 quarters · filed 2013-03-11 | $647.75K 10-K · filed 2013-03-11 | -$4.64M 10-K · filed 2012-03-20 | |||
| 2011-09-30 | -$1.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-13 | -$3.83M derived: sum of 2 quarters · filed 2012-11-13 | -$779.04K 10-Q · filed 2012-11-13 | -$3.14M 10-Q · filed 2011-11-10 | -$2.18M derived: sum of 4 quarters · filed 2012-11-13 | |||
| 2011-06-30 | -$2.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | $810.73K 10-Q · filed 2012-08-14 | $1.50M 10-Q · filed 2011-08-12 | -$595.11K derived: sum of 3 quarters · filed 2012-08-15 | -$2.52M derived: sum of 4 quarters · filed 2012-08-15 | |||
| 2011-03-31 | $3.05M 10-Q · filed 2012-05-11 | $1.64M derived: sum of 2 quarters · filed 2012-08-15 | -$280.95K derived: sum of 3 quarters · filed 2012-08-15 | |||||
| 2010-12-31 | -$1.41M derived: 8-K 12 month − 10-Q 9 month · filed 2012-08-15 | -$3.33M derived: sum of 2 quarters · filed 2012-08-15 | $0.00 8-K · filed 2012-08-15 | $7.47M 10-K · filed 2012-03-20 | ||||
| 2010-09-30 | -$1.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-10 | $1.41M 10-Q · filed 2011-11-10 | ||||||
| 2010-06-30 | $3.33M 10-Q · filed 2011-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |